Lataa...
Synergistic antitumor effects of a TGFβ inhibitor and cyclophosphamide
In a mouse model of breast carcinoma, the combination of cyclophosphamide and transforming growth factor β1,2,3 (TGFβ1,2,3)-targeting antibody achieved superior antineoplastic effects. This novel paradigm of synergistic chemoimmunotherapy promises to improve the clinical outcome of cancer patients w...
Tallennettuna:
| Päätekijät: | , , |
|---|---|
| Aineistotyyppi: | Artigo |
| Kieli: | Inglês |
| Julkaistu: |
Landes Bioscience
2014
|
| Aiheet: | |
| Linkit: | https://ncbi.nlm.nih.gov/pmc/articles/PMC4063140/ https://ncbi.nlm.nih.gov/pubmed/25050195 https://ncbi.nlm.nih.govhttp://dx.doi.org/10.4161/onci.28247 |
| Tagit: |
Lisää tagi
Ei tageja, Lisää ensimmäinen tagi!
|